PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,396 stories, page 34 of 807

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Agios Pharmaceuticals Announces FDA Extends Review of Mitapivat sNDA for Sickle Cell Disease to February 1, 2027

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Biokin Pharmaceutical Co: Q3 earnings rebounded, while 9M losses and R&D-driven cash outflow remained substantial

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Adult social care client level data, England: quarterly update to March 2026

Official statistics in development on insights from client level data from local authorities, includ...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Agios sickle cell drug FDA review extended to Feb. 1, 2027 | AGIO Stock News

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The FDA approved ketamine without a preservative found in every currently available ketamine injection.

Stock TitanOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Adult social care client level data, England: quarterly update

Official statistics in development on insights from client level data from local authorities, includ...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

MHRA Safety Roundup: October 2026

MHRA UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jefferies raises Fortrea stock price target on biotech traction By Investing.com

Investing.com CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Henlius Shortlisted for Four Scrip and Citeline Awards, Including Three for the ASTRUM-006 Study of Serplulimab

google_newsOriginal source
🇩🇪pharma_equipmentsyntegon.comTier 2 · Direct publisher

ISPE FOYA Award for our customer Hepalink

Syntegon (Bosch Packaging)Original source
🌍discoverynews.google.comTier 2 · Trade media

New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs

BioSpaceOriginal source
🇪🇸Researchclinicbarcelona.orgTier 2 · Direct publisher

The Clínic’s Teachers: A Bridge Between School and Hospital

Hospital Clínic de BarcelonaOriginal source
🇫🇷Researchchu-toulouse.frTier 2 · Direct publisher

Enquête auprès des patient·es et visiteur·ses : quels modes de transport utilisez-vous pour venir au CHU de Toulouse ?

CHU de ToulouseOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

New report shows toll of Chickenpox with over 3,000 infants hospitalised last year

Parents urged to ensure children are protected with free vaccine now available as part of NHS Childh...

UK Health Security AgencyOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: iRNA|CAR-T: An All-RNA Platform for Durable In Vivo Generation of Cancer-Specific CAR-T Cells

CORDISOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 1 November 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🇺🇸Researchaacr.orgTier 2 · Direct publisher

From the Bench, Fall 2026: Virtual Cells, Talking Cells, Eating Cells, and More

AACROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech leads call for Ramaswamy to remove attack ad: The Wake Up for Friday, Oct. 30, 2026

Cleveland.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Don’t let a winter bug ruin your Diwali celebrations

UKHSA urges those eligible to get vaccinated as soon as possible – help protect yourself and stop th...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Watch: Is biotech’s future full of zero-employee startups?

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhangzhou Pientzehuang Pharmaceutical Q3 Net Profit Down 71.67% Y/Y

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhangzhou Pientzehuang Pharmaceutical: Q3 earnings fell sharply as pharmaceutical profits and subsidiary investment income weakened

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A CT doctor worked on the new melanoma vaccine trials. Why she says it offers hope

Hartford CourantOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Varicella epidemiological reports

Surveillance data on varicella cases in England.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Td/IPV (3-in-one) teenage vaccine: VGD template

Vaccine group direction (VGD) template to support delivery of the national vaccination programme for...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Diphtheria, tetanus and inactivated poliomyelitis vaccine: patient group direction template

Patient group direction (PGD) template to support the national diphtheria, tetanus and inactivated p...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Immunisation patient group direction (PGD) templates

PGD templates to support national immunisation programmes provided on the NHS.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Adult social care client level data, England: quarterly update to September 2026

Official statistics in development on insights from client level data from local authorities, includ...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Adult social care client level data, England: quarterly update to June 2026

Official statistics in development on insights from client level data from local authorities, includ...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A 76-Year-Old Kidney Patient Became Convinced She Was Dead, and Doctors Blamed a Common Antibiotic

inklOriginal source
🇳🇱Researcheur.nlTier 2 · Direct publisher

Rommert Dekker wins Best Paper Award at EETN Conference on Artificial Intelligence

Erasmus University RotterdamOriginal source
🌍discoverynews.google.comTier 2 · Trade media

AstraZeneca cuts early-phase prostate cancer pipeline

Fierce BiotechOriginal source
🌍Associationkff.orgTier 2 · Direct publisher

The Average Monthly Premium for Medicare Part D Stand-Alone Plans Is Projected to Increase by 50% From $34 to $51 in 2027 Unless Enrollees Switch to Lower-Cost Plans

KFF (Kaiser Family Foundation) HealthOriginal source
🌍Associationkff.orgTier 2 · Direct publisher

Medicare Part D Premiums and Cost Sharing in 2027

KFF (Kaiser Family Foundation) HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ethiopia to become hub for pharmaceutical manufacturing in Africa

TV BRICSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

When the “Standard of Care” Fails the Trial: What PROSpect’s Negative Findings Reveal About Pediatric Critical Care’s Evidence Crisis

The Clinical Trial VanguardOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National Chlamydia Screening Programme (NCSP)

Information, data, guidance and resources about the NCSP.

UK Health Security AgencyOriginal source
🇩🇪Researchembl.orgTier 2 · Direct publisher

Watching ribosomes in the making all at once

European Molecular Biology Laboratory (EMBL)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Guest Post: What Makes The Next Breakthrough Possible? Lessons From The 'Fosbury Flop' For AI and Quantum in Biotech

The Quantum InsiderOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Environmental monitoring following the Grenfell Tower fire

Air quality reports for the survivors and residents of the area surrounding Grenfell Tower.

UK Health Security AgencyOriginal source
🇩🇪Researchuni-freiburg.deTier 2 · Direct publisher

From Christmas tree ornaments to a patent: Measurement technology for the forest of the future

University of FreiburgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NFL Biosciences seeks a partner for the phase 3 trial of NFL-101 at the BIO-Europe conference

Idéal InvestisseurOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Bambusa shoots past IPO targets as Aspen trims offering

Fierce BiotechOriginal source
🇪🇸Researchclinicbarcelona.orgTier 2 · Direct publisher

A computational model reveals that the brain’s molecular heterogenety is key to neural communication

Hospital Clínic de BarcelonaOriginal source
🇯🇵Researchhosp.tohoku.ac.jpTier 2 · Direct publisher

第63回円形脱毛症の患者会 患者セミナー開催のお知らせ（11/8開催）

Tohoku University HospitalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Roche launches differential diagnosis test for mesothelioma

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioVersys initiates Phase 2b trial for anti infective drug BV100

Vietnam Investment Review - VIROriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 45 report: data to week 44 (data up to 1 November 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Formation raises $600 million to fix AI's biotech bottleneck

AxiosOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NOPARK phase 3 clinical trial publishes results

Cure Parkinson'sOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NFL Biosciences will participate in the BIO-Europe 2026 conference to continue discussions with potential partners regarding NFL-101 and NFL-102

Yahoo Finance AustraliaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Molecular Partners to lay off up to 44% of workforce in radiotherapy pivot

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Inc. Tokenized Stock (Ondo) price today, BMRNon to USD live price, marketcap and chart

CoinMarketCapOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Navigating geopolitical risks: Practical and legal mitigations for the pharmaceutical industry

pharmaphorumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharma shares rise 2%; gets US FDA approval for ILUMYA to treat psoriatic arthritis

The Financial ExpressOriginal source
🌍Industryhealth.ucdavis.eduTier 1 · Company source

UC Davis podcast, Unfold, wins two national Signal Awards

UC Davis HealthOriginal source
🇨🇭Researchusz.chTier 2 · Direct publisher

Innosuisse-Förderung für «PhariX»

Universitätsspital Zürich (USZ)Original source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Announces Variances Between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2026 and Revisions to Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 2027

Sumitomo PharmaOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Announces Revision of Its Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2027

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. eases restrictions on six unapproved peptides despite FDA safety concerns

QazinformOriginal source